Creatinine Levels and Cardiovascular Events in Women with Heart Disease: Do Small Changes Matter?

American Journal of Kidney Diseases

Volumn 43, Issue 1, 2004, Pages 37-44

  Shlipak, Michael G ^a   Stehman Breen, Catherine ^b   Vittinghoff, Eric ^b   Lin, Feng ^b   Varosy, Paul D ^b   Wenger, Nanette K ^b   Furberg, Curt D ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cardiovascular disease; Chronic kidney disease (CKD); Creatinine levels; Epidemiology; Women

Indexed keywords

CONJUGATED ESTROGEN; CREATININE; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOMES RESEARCH; POSTMENOPAUSE; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0346728941     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.08.044     Document Type: Article

References (17)

1. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
2. Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001
3. Fried LF, Shlipak MG, Crump C, et al: Mild renal insufficiency as a predictor of cardiovascular outcomes and all-cause mortality in elderly individuals. J Am Coll Cardiol 41:1364-1372, 2003
4. Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280:605-613, 1998
5. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38:705-711, 2001
6. Gottlieb SS, Abraham W, Butler J, et al: The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8:136-141, 2002
7. Smith GL, Vaccarino V, Kosiborod M, et al: Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9:13-25, 2003
8. Krumholz HM, Chen YT, Vaccarino V, et al: Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85:1110-1113, 2000
9. Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB: Heart and Estrogen/Progestin Replacement Study (HERS): Design, methods, and baseline characteristics. Control Clin Trials 19:314-335, 1998
10. Grady D, Herrington D, Bittner V, et al: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 288:49-57, 2002
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
12. Vittinghoff E, Shlipak MG, Varosy PD, et al: Risk factors and secondary prevention in women with heart disease: The Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 138:81-89, 2003
13. Shlipak MG, Fried LF, Crump C, et al: Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62:997-1004, 2002
14. Shlipak MG, Fried LF, Crump C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92, 2003
15. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
16. Zoccali C, Bode-Boger S, Mallamaci F, et al: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358:2113-2117, 2001
17. Coresh J, Toto RD, Kirk KA, et al: Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis 32:32-42, 1998